NFL Reviews Eagles' Care of Jalen Hurts

Independent medical experts will review the Philadelphia Eagles' treatment of quarterback Jalen Hurts after blood clots sidelined him.

Updated on Nov. 22, 2026 in Football

NFL Reviews Eagles' Care of Jalen Hurts

The NFL said independent medical experts will review the Philadelphia Eagles' medical treatment of quarterback Jalen Hurts, who was diagnosed with a superficial blood clot in his calf and later found to have bilateral pulmonary emboli, or blood clots in both lungs. Hurts has been prescribed blood thinners, placed on injured reserve and is expected to miss the rest of the season.

Why it matters

The review follows a letter from U.S. Sen. Lisa Blunt Rochester to NFL Commissioner Roger Goodell raising concerns about the team's care, and the NFL Players Association has demanded an investigation into how the league handled Hurts' health needs. Its outcome could lead to league-wide guidance on monitoring and treating blood clots.

Blood clots affect about 900,000 Americans annually and cause roughly 100,000 deaths per year, according to the CDC. The independent review's findings and whether the case prompts league-wide guidance remain unresolved.

The players

Jalen Hurts

Jalen Hurts is the starting quarterback of the Philadelphia Eagles, a former Oklahoma standout who led the team to a Super Bowl appearance.

Lisa Blunt Rochester

Lisa Blunt Rochester is a U.S. senator from Delaware who raised concerns about the Eagles' care of Hurts in a letter to the NFL.

Roger Goodell

Roger Goodell is the commissioner of the National Football League, overseeing league policy and player health matters.

National Football League

The National Football League is the professional American football league that announced the independent medical review.

The details

Hurts told Eagles medical personnel on Oct. 8 that he had been cleated during the Oct. 4 game against the Los Angeles Rams. An ultrasound after the Oct. 11 London game against the Jacksonville Jaguars found a superficial blood clot in his calf, and further testing after he flew back to the U.S. showed the clot had moved to his lungs.

Timeline

  1. Oct. 4, 2026: Hurts is cleated in the game against the Rams.

  2. Oct. 8, 2026: Hurts informs Eagles medical staff of the cleating.

  3. Oct. 11, 2026: Hurts plays in the London game against the Jaguars, where a calf clot is found.

  4. Oct. 19, 2026: Eagles and Hurts' agent disclose the lung clots.

  5. Nov. 6, 2026: NFL executive vice president Jeff Miller replies to Blunt Rochester.

Big Picture

Senator Lisa Blunt Rochester's letter draws on her own loss, as her husband Charles died after blood clots traveled from an Achilles tendon tear to his heart and lungs. The NFL review now tests whether a player's clot case will push the league toward formal protocols.

The outcome could affect how the league monitors players for blood clots after injuries and surgeries. Hurts is expected to miss the rest of the season, which removes the Eagles' starting quarterback from the lineup for the remainder of the year.

The takeaway

The case shows how a single player's blood clot can prompt league-level questions about monitoring and treatment. Watching whether the review results in written guidance will show whether the issue moves beyond one team.

Further reading

For more on the team at the center of the review, see Football coverage tied to Philadelphia.

Source note: This article includes information reported by WHYY.